T cell activation occurs when an APC presents tumor Ag via major histocompatibility complex (MHC) to the TCR, leading to interaction between costimulatory receptor CD28 on the T cell and B7 (specifically CD80 and CD86) on an APC. Here, CD80 is linked to neoplasm.